Cargando…

Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma

To determine predictive factors for temporal lobe injury (TLI) in nasopharyngeal carcinoma patient (NPC) treated with intensity‐modulated radiation therapy (IMRT). A total of 695 NPC cases treated with IMRT were retrospectively analyzed. TLI was diagnosed on MRI images. Volume‐dose histograms for 87...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Mei, Huang, Yecai, Fan, Xigang, Xu, Peng, Lang, Jinyi, Wang, Dian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852358/
https://www.ncbi.nlm.nih.gov/pubmed/29473319
http://dx.doi.org/10.1002/cam4.1291
_version_ 1783306555627667456
author Feng, Mei
Huang, Yecai
Fan, Xigang
Xu, Peng
Lang, Jinyi
Wang, Dian
author_facet Feng, Mei
Huang, Yecai
Fan, Xigang
Xu, Peng
Lang, Jinyi
Wang, Dian
author_sort Feng, Mei
collection PubMed
description To determine predictive factors for temporal lobe injury (TLI) in nasopharyngeal carcinoma patient (NPC) treated with intensity‐modulated radiation therapy (IMRT). A total of 695 NPC cases treated with IMRT were retrospectively analyzed. TLI was diagnosed on MRI images. Volume‐dose histograms for 870 evaluable temporal lobes were analyzed, and the predictive factors for the occurrence of TLI was evaluated. Receiver operating characteristic curve (ROC) and Logistic regression analysis was used to determine volume‐dose parameters that predict temporal lobe injury (TLI). Univariate and multivariate analysis were used to analyze the predictive factors for TLI. The radiation dose‐tolerance model of temporal lobe was calculated by logistic dose‐response model. The median follow‐up time was 73 months. A total of 8.5% patients were diagnosed with TLI. Among all the volume‐dose parameters, logistic regression model showed D2cc (the dose Gray delivered to 2 cubic centimeter volume) was an only independent predictive factor. Multivariate analysis showed D2cc of temporal lobe, fraction size of prescription, T stage, and chemotherapy were the independent predictive factors for TLI. Logistic dose‐response model has indicated the TD (5/5) and TD (50/5) of D2cc are 60.3 Gy and 76.9 Gy, respectively. D2cc of temporal lobe, fraction size of prescription, T stage, and chemotherapy were the possible independent predictive factors for TLI after IMRT of NPC. Biologic effective doses (TD (5/5) and TD (50/5)) of D2cc are considered to prevent TLI.
format Online
Article
Text
id pubmed-5852358
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58523582018-03-22 Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma Feng, Mei Huang, Yecai Fan, Xigang Xu, Peng Lang, Jinyi Wang, Dian Cancer Med Clinical Cancer Research To determine predictive factors for temporal lobe injury (TLI) in nasopharyngeal carcinoma patient (NPC) treated with intensity‐modulated radiation therapy (IMRT). A total of 695 NPC cases treated with IMRT were retrospectively analyzed. TLI was diagnosed on MRI images. Volume‐dose histograms for 870 evaluable temporal lobes were analyzed, and the predictive factors for the occurrence of TLI was evaluated. Receiver operating characteristic curve (ROC) and Logistic regression analysis was used to determine volume‐dose parameters that predict temporal lobe injury (TLI). Univariate and multivariate analysis were used to analyze the predictive factors for TLI. The radiation dose‐tolerance model of temporal lobe was calculated by logistic dose‐response model. The median follow‐up time was 73 months. A total of 8.5% patients were diagnosed with TLI. Among all the volume‐dose parameters, logistic regression model showed D2cc (the dose Gray delivered to 2 cubic centimeter volume) was an only independent predictive factor. Multivariate analysis showed D2cc of temporal lobe, fraction size of prescription, T stage, and chemotherapy were the independent predictive factors for TLI. Logistic dose‐response model has indicated the TD (5/5) and TD (50/5) of D2cc are 60.3 Gy and 76.9 Gy, respectively. D2cc of temporal lobe, fraction size of prescription, T stage, and chemotherapy were the possible independent predictive factors for TLI after IMRT of NPC. Biologic effective doses (TD (5/5) and TD (50/5)) of D2cc are considered to prevent TLI. John Wiley and Sons Inc. 2018-02-23 /pmc/articles/PMC5852358/ /pubmed/29473319 http://dx.doi.org/10.1002/cam4.1291 Text en © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Feng, Mei
Huang, Yecai
Fan, Xigang
Xu, Peng
Lang, Jinyi
Wang, Dian
Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma
title Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma
title_full Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma
title_fullStr Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma
title_full_unstemmed Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma
title_short Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma
title_sort prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852358/
https://www.ncbi.nlm.nih.gov/pubmed/29473319
http://dx.doi.org/10.1002/cam4.1291
work_keys_str_mv AT fengmei prognosticvariablesfortemporallobeinjuryafterintensitymodulatedradiotherapyofnasopharyngealcarcinoma
AT huangyecai prognosticvariablesfortemporallobeinjuryafterintensitymodulatedradiotherapyofnasopharyngealcarcinoma
AT fanxigang prognosticvariablesfortemporallobeinjuryafterintensitymodulatedradiotherapyofnasopharyngealcarcinoma
AT xupeng prognosticvariablesfortemporallobeinjuryafterintensitymodulatedradiotherapyofnasopharyngealcarcinoma
AT langjinyi prognosticvariablesfortemporallobeinjuryafterintensitymodulatedradiotherapyofnasopharyngealcarcinoma
AT wangdian prognosticvariablesfortemporallobeinjuryafterintensitymodulatedradiotherapyofnasopharyngealcarcinoma